• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Masimo

Anonymous board for Masimo
Replies
17
Views
3K
anonymous
Replies
2
Views
1K
anonymous
Replies
0
Views
759
anonymous
Replies
3
Views
771
anonymous
Run
Replies
0
Views
2K
Former sales employees
Replies
16
Views
6K
anonymous
Replies
1
Views
2K
anonymous
Replies
1
Views
3K
anonymous
Replies
192
Views
79K
anonymous
Replies
0
Views
2K
anonymous
Replies
40
Views
17K
anonymous
Replies
4
Views
5K
anonymous
Replies
223
Views
98K
anonymous
Replies
1
Views
3K
anonymous
Replies
0
Views
2K
Anonymous
Replies
3
Views
3K
Anonymous
Replies
0
Views
3K
Patient Safety Frowndation
Replies
3
Views
3K
Anonymous
Replies
2
Views
6K
Anonymous